Showing 23,074 news articles about PEP

Filters Content type: Editors' picks Topic: PEP

Post-exposure prophylaxis involves taking a 28-day course of anti-HIV drugs, after possible exposure to HIV. It may be used by healthcare workers (occupational PEP) or after sex (post-exposure prophylaxis after sexual exposure, PEPSE, also known as non-occupational PEP or nPEP).

Hepatitis C transmission & prevention

Hepatitis C linked to ink

Editor's pick
Reuters
25 January 2013
Hepatitis C transmission & prevention

Online tattoo and piercing kits could be spreading Hepatitis C

Editor's pick
NEWS.com.au
18 January 2013
New & experimental hepatitis C treatment

Achillion Continues To Make Significant Strides In The Fight Against Hepatitis C

Editor's pick
Seeking Alpha
15 January 2013
New & experimental hepatitis C treatment

Idenix May Drop Delayed Hepatitis C Drug for New Versions

Editor's pick
Businessweek
10 January 2013
Hepatitis C symptoms & diagnosis

Year in Review: Dueling HCV Screening Recommendations

Editor's pick
MedPage Today
3 January 2013
Hepatitis C symptoms & diagnosis

UAE to launch Hep-C awareness

Editor's pick
Bahrain News Agency
21 December 2012
Hepatitis C treatment side-effects

Vertex hepatitis C drug Incivek gets 'black box' warning over possible fatal skin conditions

Editor's pick
Washington Post
20 December 2012
Hepatitis C treatment

Accessing Hepatitis C Patients Who Are Difficult to Reach

Editor's pick
Medscape (requires registration)
17 December 2012
Hepatitis C treatment

Though Hepatitis C Patients Report Having Equal Influence with Their Treating Physicians Regarding the Management and Treatment of Their Disease, Very Few Have Ever Requested Specific Products for Treatment

Editor's pick
Market Watch (press release)
13 December 2012
Hepatitis C symptoms & diagnosis

Aging Hepatitis C Population Escalates Demand for Liver Transplantation

Editor's pick
Science Daily
12 December 2012
Hepatitis C transmission & prevention

Medical Technician Accused in Hepatitis C Infections Is Indicted on New Charges

Editor's pick
New York Times
3 December 2012
Hepatitis C treatment

Hepatitis C Reaching Crisis Levels; Requires Coverage for Routine Screenings

Editor's pick
National Summit on HIV and Viral Hepatitis press release
28 November 2012
Hepatitis C symptoms & diagnosis

Less Support for Hepatitis C Testing for Baby Boomers

Editor's pick
New York Times
27 November 2012
Hepatitis C symptoms & diagnosis

HCV Screening Benefit Still Uncertain

Editor's pick
MedPage Today
27 November 2012
Hepatitis C treatment

Devon Nicholson Hep C treatment Chronicles – Week 4 – “Blood Work and Virus Tests"

Editor's pick
Net Newsledger
26 November 2012
Access to healthcare

Pakistan: Hepatitis C treatment: Produce cheap injections immediately, orders PAC

Editor's pick
The Express Tribune
20 November 2012
Hepatitis C treatment side-effects

FDA approves Glaxo-Ligand platelet drug for hepatitis C patients

Editor's pick
Reuters
20 November 2012
New & experimental hepatitis C treatment

Hep C Competitors Cede Space To Gilead And Bristol-Myers And Turn To Niche Uses

Editor's pick
Seeking Alpha
13 November 2012
New & experimental hepatitis C treatment

Gilead Climbs on Study Results of Hepatitis C Combination

Editor's pick
Bloomberg
12 November 2012
New & experimental hepatitis C treatment

Boehringer Ingelheim to start late-stage hepatitis C drug trial

Editor's pick
Reuters
11 November 2012
Hepatitis C transmission & prevention

Hepatits C could be eliminated from cities, leading specialist says

Editor's pick
GP Online
5 November 2012
Pharmaceutical industry

Gilead and the Pharmasset Deal: Do the Ends Justify the Means?

Editor's pick
PropThink
5 November 2012
Access to healthcare

IPAB revokes patent on Roche Hepatitis C drug

Editor's pick
Hindu Business Line
2 November 2012
New & experimental hepatitis C treatment

Vertex Joins Glaxo, J&J in Testing Hepatitis C Combos

Editor's pick
Bloomberg BusinessWeek
1 November 2012